维普期刊资源整合服务平台（V6.5）

595篇 您的检索式：作者名="HIDESHIMA T"

选中清除导出查看参考文献查看引证文献引用追踪共30页首页上一页第1页下一页末页 /30 跳转

	题名	作者	年代	出处	被引量
1	Thalidomide and immunomodu latory derivatives augment natural killer cell cytotoxicity in multiple myeloma显示文摘	Davies FE Raje N Hideshima T		0，，：	2
2	Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma显示文摘	Davies FE Raje N Hideshima T	2001	Blood2001，98，1：	1
3	A novel proteasome inhibitor NPI-0052 as an anticancer therapy显示文摘	Chauhan D Hideshima T Anderson K C	2006	British J Cancer2006，95，8：	1
4	Novel the- rapeutic strategies targeting growth factor signalling cas- cades in multiple myeloma显示文摘	Yasui H Hideshima T Richardson PG	2006	Br J Haematol2006，132，4：	1
5	Thalidomide:Emerging role in cancer medicine显示文摘	Richardson P Hideshima T Anderson K	2002	Annu Rev Med2002，53，：	1
6	Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma 显示文摘	Hideshima T Nakamura N Chanhan D	2001	Oncogene2001，20，42：	1
7	Arsenic trioxide inhibits growth of human multiple myeloma cells in the bone marrow microenvironment 显示文摘	Hideshima T Akiyama M	2002	Mol Cancer Ther2002，1，10：	1
8	Bortezomib mediates antiangi ogenesis in multiple myeloma via direct and indirect effects on endothelia1cells显示文摘	Roccaro AM Hideshima T Raje N et a1	2006	Cancer Ras2006，66，1：	1
9	Proteasome inhibition as a novel therapeutic target in human cancer显示文摘	Rajkumar SV Richardson PG Hideshima T	2005	J Clin Oncol2005，23，3：	1
10	Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase - dependent and - independent apoptosis 显示文摘	Ishitsuka K Hideshima T Hamasaki M	2005	Blood2005，106，5：	1
11	The role of tumor necrosis factor alpha in the pathophysiology ofhuman multiple myeloma: therapeutic applications 显示文摘	Hideshima T Chauhan D Sehlossman R	2001	Oncogene2001，20，：	1
12	Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxieity in multiple myeloma显示文摘	Davies FE Raje N Hideshima T	2001	Blood2001，98，1：	1
13	Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mu- tation 显示文摘	Matsuzoe D Hideshima T Ohshima K	1999	Br J Cancer1999，79，910：	1
14	Novel inosine monophosphate dehydrogenase inhibitor VX-944 induces apoptosis in multiple myeloma ceils primarily via caspaseindependent AIF/Endo G pathway显示文摘	Ishitsuka K Hideshima T Hamasaki M	2005	Oncogene2005，24，38：	1
15	Arsenic trioxide inhibits growth of human multiple myeloma cells in the bone marrow microenvironment显示文摘	Hayashi T Hideshima T Akiyama M	2002	Mol Cancer T her2002，1，10：	1
16	Molecular mechanisms whereby immunomodulatory drugs activate natural killer cells: clinical application显示文摘	Hayashi T Hideshima T Akiyama M	2005	Br J Haematol2005，128，2：	1
17	Small-molecule inhibi- tion of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma 显示文摘	Hideshima T Brandner JE Wong J	2005	Proc Natl Acad Sci USA2005，102，24：	1
18	Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy显示文摘	HIDESHIMA T CHAUHAN D SHIMA Y	2000	Blood2000，96，9：	1
19	A high-affinity fully human anti-IL-6 mAb, 1339, for the treatment of multiple myeloma显示文摘	Fuleiniti M Hideshima T Vermot-Desroches C	2009	Clin Cancer Res2009，15，23：	1
20	Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma显示文摘	FULCINITI M TASSONE P HIDESHIMA T	2009	Blood2009，114，2：	1

返回顶部每页显示：

共30页首页上一页第1页下一页末页 /30 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示